OOIR: Observatory of International Research

Papers

(The H4-Index of ChemMedChem is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Drug Development and Medicinal Chemistry Efforts toward SARS‐Coronavirus and Covid‐19 Therapeutics	221
Small‐Molecule Inhibitors of METTL3, the Major Human Epitranscriptomic Writer	102
Therapeutic Strategies To Counteract Antibiotic Resistance in MRSA Biofilm‐Associated Infections	87
Antitumour Anthracyclines: Progress and Perspectives	86
METTL3 Inhibitors for Epitranscriptomic Modulation of Cellular Processes	84
A Quick Route to Multiple Highly Potent SARS‐CoV‐2 Main Protease Inhibitors**	84
Porphyrin‐Based Metal−Organic Framework Compounds as Promising Nanomedicines in Photodynamic Therapy	63
Cyclobutanes in Small‐Molecule Drug Candidates	56
Recent Development of Pyrimidine‐Containing Antimicrobial Agents	54
Strategies To Design Selective Histone Deacetylase Inhibitors	52
Pectin: A Long‐Neglected Broad‐Spectrum Antibacterial	51
The Critical Role of Passive Permeability in Designing Successful Drugs	51
Recent Advances in the Prediction of Pharmacokinetics Properties in Drug Design Studies: A Review	44
Recent Advances in Radiometals for Combined Imaging and Therapy in Cancer	43
2‐Isoxazolines: A Synthetic and Medicinal Overview	42
Benzimidazoles in Drug Discovery: A Patent Review	41
Cationic Amphiphilic Peptides: Synthetic Antimicrobial Agents Inspired by Nature	40
Copper: An Intracellular Achilles’ Heel Allowing the Targeting of Epigenetics, Kinase Pathways, and Cell Metabolism in Cancer Therapeutics	39
Coinage Metal N‐Heterocyclic Carbene Complexes: Recent Synthetic Strategies and Medicinal Applications	38
A Patent Review on the Current Developments of Benzoxazoles in Drug Discovery	36
E7766, a Macrocycle‐Bridged Stimulator of Interferon Genes (STING) Agonist with Potent Pan‐Genotypic Activity	35
Malaria Pigment Crystals: The Achilles′ Heel of the Malaria Parasite	34
Cyclic Dipeptide: A Privileged Molecular Scaffold to Derive Structural Diversity and Functional Utility	34
Recent Drug Development and Medicinal Chemistry Approaches for the Treatment of SARS‐CoV‐2 Infection and COVID‐19	33
When Virtual Screening Yields Inactive Drugs: Dealing with False Theoretical Friends	33

MPI8 is Potent against SARS‐CoV‐2 by Inhibiting Dually and Selectively the SARS‐CoV‐2 Main Protease and the Host Cathepsin L**	33
Piperazine, a Key Substructure for Antidepressants: Its Role in Developments and Structure‐Activity Relationships	32
Structure‐Activity Relationships of Benzamides and Isoindolines Designed as SARS‐CoV Protease Inhibitors Effective against SARS‐CoV‐2	32
1,2,4‐Oxadiazole Topsentin Analogs with Antiproliferative Activity against Pancreatic Cancer Cells, Targeting GSK3β Kinase	31
New Antivirals and Antibacterials Based on Silver Nanoparticles	30
O‐GlcNAcase: Emerging Mechanism, Substrate Recognition and Small‐Molecule Inhibitors	30